Vldlr (very low density lipoprotein receptor) - Rat Genome Database

Send us a Message



 Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap)  (beta) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer) Overgo Probe Designer
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease COVID-19 Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models PhenoMiner (Quantitative Phenotypes) Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes GERRC (Gene Editing Rat Resource Center) Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Poster Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Gene: Vldlr (very low density lipoprotein receptor) Rattus norvegicus
Analyze
Symbol: Vldlr
Name: very low density lipoprotein receptor
RGD ID: 3963
Description: Predicted to enable several functions, including reelin receptor activity; very-low-density lipoprotein particle binding activity; and very-low-density lipoprotein particle receptor activity. Involved in several processes, including cellular response to glucose starvation; cellular response to interleukin-1; and cellular response to lipopolysaccharide. Located in several cellular components, including apical part of cell; cell surface; and perinuclear region of cytoplasm. Biomarker of focal segmental glomerulosclerosis and nephrotic syndrome. Human ortholog(s) of this gene implicated in Alzheimer's disease; cerebellar ataxia, mental retardation and dysequlibrium syndrome; and dementia. Orthologous to human VLDLR (very low density lipoprotein receptor); PARTICIPATES IN altered Reelin signaling pathway; Reelin signaling pathway; INTERACTS WITH (+)-schisandrin B; 17alpha-ethynylestradiol; 17beta-estradiol.
Type: protein-coding
RefSeq Status: VALIDATED
Previously known as: very low-density lipoprotein receptor; VLDL receptor; VLDL-R
RGD Orthologs
Human
Mouse
Chinchilla
Bonobo
Dog
Squirrel
Pig
Green Monkey
Naked Mole-Rat
Alliance Genes
More Info more info ...
Latest Assembly: mRatBN7.2 - mRatBN7.2 Assembly
Position:
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
mRatBN7.21224,813,539 - 224,850,400 (+)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl1224,814,377 - 224,845,920 (+)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx1233,244,716 - 233,276,159 (+)NCBIRnor_SHR
UTH_Rnor_SHRSP_BbbUtx_1.01240,174,828 - 240,206,271 (+)NCBIRnor_SHRSP
UTH_Rnor_WKY_Bbb_1.01232,995,566 - 233,027,009 (+)NCBIRnor_WKY
Rnor_6.01245,236,819 - 245,273,688 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl1245,237,736 - 245,269,205 (+)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.01252,485,275 - 252,523,202 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.41230,666,736 - 230,697,748 (+)NCBIRGSC3.4RGSC_v3.4rn4RGSC3.4
RGSC_v3.11230,830,758 - 230,861,771 (+)NCBI
Celera1222,002,111 - 222,033,270 (+)NCBICelera
RH 3.4 Map11610.4RGD
Cytogenetic Map1q52NCBI
JBrowse: View Region in Genome Browser (JBrowse)
Model


Gene-Chemical Interaction Annotations     Click to see Annotation Detail View
(+)-schisandrin B  (EXP)
1,2-dichloroethane  (ISO)
1,2-dimethylhydrazine  (ISO)
17alpha-ethynylestradiol  (EXP,ISO)
17beta-estradiol  (EXP,ISO)
17beta-estradiol 3-benzoate  (EXP)
17beta-hydroxy-5alpha-androstan-3-one  (ISO)
2,2',4,4'-Tetrabromodiphenyl ether  (EXP,ISO)
2,3,7,8-tetrachlorodibenzodioxine  (EXP,ISO)
2,4-dibromophenyl 2,4,5-tribromophenyl ether  (ISO)
2-hydroxypropanoic acid  (ISO)
2-methoxyethanol  (EXP)
3,3',5,5'-tetrabromobisphenol A  (ISO)
3-chloropropane-1,2-diol  (EXP)
4,4'-diaminodiphenylmethane  (EXP,ISO)
4-hydroxyphenyl retinamide  (ISO)
6-propyl-2-thiouracil  (EXP)
7,12-dimethyltetraphene  (ISO)
8-Br-cAMP  (ISO)
acetamide  (EXP)
acrylamide  (EXP,ISO)
aflatoxin B1  (EXP)
all-trans-retinoic acid  (EXP,ISO)
AM-251  (ISO)
amiodarone  (ISO)
ammonium chloride  (EXP)
ampicillin  (ISO)
androgen antagonist  (EXP)
antirheumatic drug  (ISO)
aristolochic acid A  (ISO)
arsenite(3-)  (ISO)
arsenous acid  (ISO)
benzo[a]pyrene  (ISO)
benzo[a]pyrene diol epoxide I  (ISO)
bilirubin IXalpha  (ISO)
bisphenol A  (EXP,ISO)
Butylparaben  (EXP)
cadmium dichloride  (EXP)
carbamazepine  (ISO)
carbon nanotube  (ISO)
carmustine  (ISO)
casticin  (ISO)
CGP 52608  (ISO)
chlorpyrifos  (ISO)
choline  (ISO)
cisplatin  (EXP,ISO)
clofibrate  (ISO)
cobalt atom  (ISO)
cobalt dichloride  (ISO)
copper atom  (ISO)
copper(0)  (ISO)
copper(II) sulfate  (ISO)
cycloheximide  (ISO)
cyclophosphamide  (ISO)
cyclosporin A  (ISO)
cypermethrin  (ISO)
dexamethasone  (ISO)
diarsenic trioxide  (ISO)
diazinon  (ISO)
dibutyl phthalate  (EXP)
dichloroacetic acid  (ISO)
diclofenac  (ISO)
dioxygen  (ISO)
disodium selenite  (ISO)
diuron  (EXP)
dorsomorphin  (ISO)
doxorubicin  (ISO)
endosulfan  (EXP)
entinostat  (ISO)
enzacamene  (EXP)
epoxiconazole  (ISO)
ethanol  (ISO)
fenvalerate  (EXP)
fluoxetine  (EXP,ISO)
flutamide  (ISO)
folic acid  (ISO)
fonofos  (ISO)
formaldehyde  (ISO)
fructose  (ISO)
furan  (EXP)
gamma-hexachlorocyclohexane  (ISO)
geldanamycin  (EXP)
gemcitabine  (ISO)
genistein  (EXP,ISO)
geraniol  (ISO)
haloperidol  (EXP)
herbimycin  (EXP)
hexaconazole  (ISO)
hydrogen peroxide  (ISO)
hydroquinone  (ISO)
indometacin  (EXP)
irinotecan  (EXP)
L-methionine  (ISO)
lead diacetate  (ISO)
methamphetamine  (ISO)
methapyrilene  (EXP)
methotrexate  (ISO)
methylisothiazolinone  (ISO)
methylmercury chloride  (ISO)
mifepristone  (EXP)
mono(2-ethylhexyl) phthalate  (ISO)
Muraglitazar  (EXP)
nickel atom  (ISO)
nickel dichloride  (ISO)
nickel sulfate  (ISO)
ochratoxin A  (ISO)
olanzapine  (EXP)
oxaliplatin  (EXP)
ozone  (ISO)
paracetamol  (EXP,ISO)
parathion  (ISO)
perfluorooctane-1-sulfonic acid  (ISO)
perfluorooctanoic acid  (EXP,ISO)
phenobarbital  (ISO)
phenylmercury acetate  (ISO)
pioglitazone  (ISO)
pirinixic acid  (ISO)
potassium chromate  (ISO)
prednisolone  (ISO)
pregnenolone 16alpha-carbonitrile  (ISO)
prothioconazole  (ISO)
quercetin  (ISO)
rac-lactic acid  (ISO)
radicicol  (EXP)
rimonabant  (ISO)
rotenone  (ISO)
SB 431542  (ISO)
silver atom  (ISO)
silver(0)  (ISO)
sodium arsenite  (ISO)
streptozocin  (ISO)
succimer  (ISO)
sunitinib  (ISO)
tamoxifen  (ISO)
temozolomide  (ISO)
terbufos  (ISO)
Tesaglitazar  (EXP)
testosterone  (EXP,ISO)
tetrachloromethane  (EXP,ISO)
titanium dioxide  (ISO)
topotecan  (EXP)
Tributyltin oxide  (ISO)
trichloroethene  (EXP,ISO)
trichostatin A  (ISO)
triclosan  (ISO)
trimellitic anhydride  (ISO)
triptonide  (ISO)
troglitazone  (EXP)
Tungsten carbide  (ISO)
tunicamycin  (ISO)
urethane  (ISO)
valproic acid  (EXP,ISO)
vancomycin  (ISO)
vorinostat  (ISO)
zearalenone  (ISO)

Gene Ontology Annotations     Click to see Annotation Detail View

Cellular Component

Molecular Pathway Annotations     Click to see Annotation Detail View
References

References - curated
# Reference Title Reference Citation
1. Platelet-derived growth factor mediates tyrosine phosphorylation of the cytoplasmic domain of the low Density lipoprotein receptor-related protein in caveolae. Boucher P, etal., J Biol Chem 2002 May 3;277(18):15507-13. Epub 2002 Feb 19.
2. Prolonged correction of hyperlipidemia in mice with familial hypercholesterolemia using an adeno-associated viral vector expressing very-low-density lipoprotein receptor. Chen SJ, etal., Mol Ther. 2000 Sep;2(3):256-61.
3. Role of the macrophage very-low-density lipoprotein receptor in atherosclerotic lesion development. Eck MV, etal., Atherosclerosis. 2005 Dec;183(2):230-7. Epub 2005 Jun 24.
4. Reelin signaling is impaired in autism. Fatemi SH, etal., Biol Psychiatry. 2005 Apr 1;57(7):777-87.
5. Chronic psychotropic drug treatment causes differential expression of Reelin signaling system in frontal cortex of rats. Fatemi SH, etal., Schizophr Res. 2009 Jun;111(1-3):138-52. Epub 2009 Apr 9.
6. Rat small intestine expresses the reelin-Disabled-1 signalling pathway. Garcia-Miranda P, etal., Exp Physiol. 2010 Apr;95(4):498-507. Epub 2009 Nov 27.
7. Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium. Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
8. Rat ISS GO annotations from GOA human gene data--August 2006 GOA data from the GO Consortium
9. Protection from obesity in mice lacking the VLDL receptor. Goudriaan JR, etal., Arterioscler Thromb Vasc Biol. 2001 Sep;21(9):1488-93.
10. Dietary single cell protein reduces fatty liver in obese Zucker rats. Gudbrandsen OA, etal., Br J Nutr. 2008 Oct;100(4):776-85. Epub 2008 Mar 18.
11. VLDL receptor polymorphism, cognitive impairment, and dementia. Helbecque N, etal., Neurology 2001 May 8;56(9):1183-8.
12. Deficiency of the very low-density lipoprotein (VLDL) receptors in streptozotocin-induced diabetic rats: insulin dependency of the VLDL receptor. Iwasaki T, etal., Endocrinology. 2005 Aug;146(8):3286-94. Epub 2005 May 5.
13. Changes in cardiac lipid metabolism during sepsis: the essential role of very low-density lipoprotein receptors. Jia L, etal., Cardiovasc Res. 2006 Feb 1;69(2):545-55. Epub 2005 Dec 22.
14. Regulation of the very low density lipoprotein receptor by thyroid hormone in rat skeletal muscle. Jokinen EV, etal., J Biol Chem. 1994 Oct 21;269(42):26411-8.
15. The reelin signaling pathway: some recent developments. Jossin Y, etal., Cereb Cortex 2003 Jun;13(6):627-33.
16. Remnant lipoprotein particles are taken up into myocardium through VLDL receptor--a possible mechanism for cardiac fatty acid metabolism. Kamataki A, etal., Biochem Biophys Res Commun 2002 May 10;293(3):1007-13.
17. Reversal of hypercholesterolemia in low density lipoprotein receptor knockout mice by adenovirus-mediated gene transfer of the very low density lipoprotein receptor. Kobayashi K, etal., J Biol Chem. 1996 Mar 22;271(12):6852-60.
18. High-density rat radiation hybrid maps containing over 24,000 SSLPs, genes, and ESTs provide a direct link to the rat genome sequence. Kwitek AE, etal., Genome Res. 2004 Apr;14(4):750-7
19. Acquired VLDL receptor deficiency in experimental nephrosis. Liang K and Vaziri ND, Kidney Int. 1997 Jun;51(6):1761-5.
20. Role of secondary hyperparathyroidism in the genesis of hypertriglyceridemia and VLDL receptor deficiency in chronic renal failure. Liang K, etal., Kidney Int. 1998 Mar;53(3):626-30.
21. Genomic response of hypoxic Muller cells involves the very low density lipoprotein receptor as part of an angiogenic network. Loewen N, etal., Exp Eye Res. 2009 May;88(5):928-37. Epub 2009 Jan 8.
22. Localization of ApoER2, VLDLR and Dab1 in radial glia: groundwork for a new model of reelin action during cortical development. Luque JM, etal., Brain Res Dev Brain Res 2003 Feb 16;140(2):195-203.
23. Regulation of very-low-density lipoprotein receptor in hypertrophic rat heart. Masuzaki H, etal., Circ Res. 1996 Jan;78(1):8-14.
24. Rat ISS GO annotations from MGI mouse gene data--August 2006 MGD data from the GO Consortium
25. A variant very low density lipoprotein receptor lacking 84 base pairs of O-linked sugar domain in the human brain myelin. Nakamura Y, etal., Brain Res 1998 May 18;793(1-2):47-53.
26. Electronic Transfer of LocusLink and RefSeq Data NCBI rat LocusLink and RefSeq merged data July 26, 2002
27. Genetic association of the very low density lipoprotein (VLDL) receptor gene with sporadic Alzheimer's disease. Okuizumi K, etal., Nat Genet 1995 Oct;11(2):207-9.
28. OMIM Disease Annotation Pipeline OMIM Disease Annotation Pipeline
29. Maternal Thyroid Hormone before the Onset of Fetal Thyroid Function Regulates Reelin and Downstream Signaling Cascade Affecting Neocortical Neuronal Migration. Pathak A, etal., Cereb Cortex. 2010 Apr 5.
30. PID Annotation Import Pipeline Pipeline to import Pathway Interaction Database annotations from NCI into RGD
31. GOA pipeline RGD automated data pipeline
32. ClinVar Automated Import and Annotation Pipeline RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
33. Data Import for Chemical-Gene Interactions RGD automated import pipeline for gene-chemical interactions
34. Effect of diet on adipose tissue and skeletal muscle VLDL receptor and LPL: implications for obesity and hyperlipidemia. Roberts CK, etal., Atherosclerosis. 2002 Mar;161(1):133-41.
35. Down-regulation of lipoprotein lipase and VLDL receptor in rats with focal glomerulosclerosis. Sato T, etal., Kidney Int. 2002 Jan;61(1):157-62.
36. Proteomics profiling of nuclear proteins for kidney fibroblasts suggests hypoxia, meiosis, and cancer may meet in the nucleus. Shakib K, etal., Proteomics. 2005 Jul;5(11):2819-38.
37. Tentative Sequence Identification Numbers Tentative Sequence Data IDs. TIGR Gene Index, Rat Data
38. Rat neurological disease creeping is caused by a mutation in the reelin gene. Yokoi N, etal., Brain Res Mol Brain Res 2003 Apr 10;112(1-2):1-7.
39. Glucose deprivation accelerates VLDL receptor-mediated TG-rich lipoprotein uptake by AMPK activation in skeletal muscle cells. Zenimaru Y, etal., Biochem Biophys Res Commun. 2008 Apr 11;368(3):716-22. Epub 2008 Feb 8.
Additional References at PubMed
PMID:8083232   PMID:10571240   PMID:12526740   PMID:15082773   PMID:15950758   PMID:18778775   PMID:20711475   PMID:22429478   PMID:23382219   PMID:23990472   PMID:25644714   PMID:26751967  


Genomics

Comparative Map Data
Vldlr
(Rattus norvegicus - Norway rat)
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
mRatBN7.21224,813,539 - 224,850,400 (+)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl1224,814,377 - 224,845,920 (+)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx1233,244,716 - 233,276,159 (+)NCBIRnor_SHR
UTH_Rnor_SHRSP_BbbUtx_1.01240,174,828 - 240,206,271 (+)NCBIRnor_SHRSP
UTH_Rnor_WKY_Bbb_1.01232,995,566 - 233,027,009 (+)NCBIRnor_WKY
Rnor_6.01245,236,819 - 245,273,688 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl1245,237,736 - 245,269,205 (+)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.01252,485,275 - 252,523,202 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.41230,666,736 - 230,697,748 (+)NCBIRGSC3.4RGSC_v3.4rn4RGSC3.4
RGSC_v3.11230,830,758 - 230,861,771 (+)NCBI
Celera1222,002,111 - 222,033,270 (+)NCBICelera
RH 3.4 Map11610.4RGD
Cytogenetic Map1q52NCBI
VLDLR
(Homo sapiens - human)
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh3892,621,787 - 2,660,056 (+)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p13 Ensembl92,621,182 - 2,660,056 (+)EnsemblGRCh38hg38GRCh38
GRCh3792,621,787 - 2,660,056 (+)NCBIGRCh37GRCh37hg19GRCh37
Build 3692,611,793 - 2,644,485 (+)NCBINCBI36Build 36hg18NCBI36
Build 3492,611,802 - 2,644,478NCBI
Celera92,540,058 - 2,572,749 (+)NCBICelera
Cytogenetic Map9p24.2NCBI
HuRef92,576,882 - 2,609,583 (+)NCBIHuRef
CHM1_192,622,136 - 2,654,832 (+)NCBICHM1_1
T2T-CHM13v2.092,624,554 - 2,662,816 (+)NCBIT2T-CHM13v2.0
Vldlr
(Mus musculus - house mouse)
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCm391927,190,070 - 27,231,631 (+)NCBIGRCm39GRCm39mm39
GRCm39 Ensembl1927,193,884 - 27,231,631 (+)EnsemblGRCm39 Ensembl
GRCm381927,216,480 - 27,254,231 (+)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl1927,216,484 - 27,254,231 (+)EnsemblGRCm38mm10GRCm38
MGSCv371927,291,510 - 27,328,721 (+)NCBIGRCm37MGSCv37mm9NCBIm37
MGSCv361927,284,529 - 27,316,717 (+)NCBIMGSCv36mm8
Celera1928,001,119 - 28,038,314 (+)NCBICelera
Cytogenetic Map19C1NCBI
cM Map1921.77NCBI
Vldlr
(Chinchilla lanigera - long-tailed chinchilla)
Chinchilla AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
ChiLan1.0 EnsemblNW_0049554347,013,092 - 7,050,103 (+)EnsemblChiLan1.0
ChiLan1.0NW_0049554347,013,092 - 7,050,103 (+)NCBIChiLan1.0ChiLan1.0
VLDLR
(Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
PanPan1.192,621,325 - 2,653,980 (+)NCBIpanpan1.1PanPan1.1panPan2
PanPan1.1 Ensembl92,621,199 - 2,653,980 (+)Ensemblpanpan1.1panPan2
Mhudiblu_PPA_v092,428,639 - 2,463,796 (+)NCBIMhudiblu_PPA_v0Mhudiblu_PPA_v0panPan3
VLDLR
(Canis lupus familiaris - dog)
Dog AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
CanFam3.1191,242,010 - 91,277,030 (+)NCBICanFam3.1CanFam3.1canFam3CanFam3.1
CanFam3.1 Ensembl191,241,509 - 91,272,495 (+)EnsemblCanFam3.1canFam3CanFam3.1
Dog10K_Boxer_Tasha191,709,985 - 91,740,404 (+)NCBIDog10K_Boxer_Tasha
ROS_Cfam_1.0191,786,552 - 91,821,587 (+)NCBIROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl191,786,012 - 91,818,969 (+)EnsemblROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.1191,433,922 - 91,464,358 (+)NCBIUMICH_Zoey_3.1
UNSW_CanFamBas_1.0191,145,967 - 91,176,393 (+)NCBIUNSW_CanFamBas_1.0
UU_Cfam_GSD_1.0191,920,678 - 91,951,114 (+)NCBIUU_Cfam_GSD_1.0
Vldlr
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
HiC_Itri_2NW_024404947138,732,746 - 138,766,426 (+)NCBIHiC_Itri_2
SpeTri2.0 EnsemblNW_0049365032,405,689 - 2,440,502 (-)EnsemblSpeTri2.0
SpeTri2.0NW_0049365032,407,040 - 2,440,366 (-)NCBISpeTri2.0SpeTri2.0SpeTri2.0
VLDLR
(Sus scrofa - pig)
Pig AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Sscrofa11.1 Ensembl1219,173,507 - 219,210,343 (-)EnsemblSscrofa11.1susScr11Sscrofa11.1
Sscrofa11.11219,178,501 - 219,210,332 (-)NCBISscrofa11.1Sscrofa11.1susScr11Sscrofa11.1
Sscrofa10.21245,001,226 - 245,032,858 (-)NCBISscrofa10.2Sscrofa10.2susScr3
VLDLR
(Chlorocebus sabaeus - green monkey)
Green Monkey AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
ChlSab1.11276,900,551 - 76,933,601 (-)NCBIChlSab1.1ChlSab1.1chlSab2
ChlSab1.1 Ensembl1276,899,189 - 76,933,584 (-)EnsemblChlSab1.1ChlSab1.1 EnsemblchlSab2
Vero_WHO_p1.0NW_02366603865,238,161 - 65,273,396 (-)NCBIVero_WHO_p1.0Vero_WHO_p1.0
Vldlr
(Heterocephalus glaber - naked mole-rat)
Naked Mole-rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
HetGla_female_1.0 EnsemblNW_0046247367,280,490 - 7,316,946 (+)EnsemblHetGla_female_1.0HetGla_female_1.0 EnsemblhetGla2
HetGla 1.0NW_0046247367,280,478 - 7,316,897 (+)NCBIHetGla_female_1.0HetGla 1.0hetGla2

Variants

.
Variants in Vldlr
143 total Variants
miRNA Target Status

Predicted Target Of
Summary Value
Count of predictions:106
Count of miRNA genes:66
Interacting mature miRNAs:85
Transcripts:ENSRNOT00000035814
Prediction methods:Miranda, Targetscan
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.


QTLs in Region (mRatBN7.2)
The following QTLs overlap with this region.    Full Report CSV TAB Printer Gviewer
RGD IDSymbolNameLODP ValueTraitSub TraitChrStartStopSpecies
7794788Mcs32Mammary carcinoma susceptibility QTL 322.61mammary gland integrity trait (VT:0010552)mammary tumor incidence/prevalence measurement (CMO:0000946)1115540693238914717Rat
7421630Bp362Blood pressure QTL 3620.001arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)1118608292241799120Rat
2302378Insul11Insulin level QTL 113.25blood insulin amount (VT:0001560)serum insulin level (CMO:0000358)1144267353251128347Rat
724531Uae5Urinary albumin excretion QTL 54urine albumin amount (VT:0002871)urine albumin level (CMO:0000130)1150700142252085212Rat
1578759Uae30Urinary albumin excretion QTL 303.30.003urine albumin amount (VT:0002871)urine albumin excretion rate (CMO:0000757)1150700247252085048Rat
1578778Pur4Proteinuria QTL 43.30.003urine total protein amount (VT:0000032)urine total protein excretion rate (CMO:0000756)1150700247252085048Rat
1354610Bw34Body weight QTL 344.1body mass (VT:0001259)body weight (CMO:0000012)1151162512256448636Rat
1354646Kidm18Kidney mass QTL 185.7kidney mass (VT:0002707)calculated kidney weight (CMO:0000160)1151162512256448636Rat
1354661Bw33Body weight QTL 335.2body mass (VT:0001259)body weight (CMO:0000012)1151162512256448636Rat
1358886Bp260Blood pressure QTL 2603.67arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)1151162766225824951Rat
1549837Hcar15Hepatocarcinoma resistance QTL 150.05liver integrity trait (VT:0010547)liver tumorous lesion number (CMO:0001068)1153136852260522016Rat
1354580Scort1Serum corticosterone level QTL 13.4blood corticosterone amount (VT:0005345)blood corticosterone level (CMO:0001172)1156677124256448636Rat
2292220Bp306Blood pressure QTL 3063.470.00087arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)1164310393243914901Rat
738032Hcas5Hepatocarcinoma susceptibility QTL 53.12liver integrity trait (VT:0010547)liver tumorous lesion number (CMO:0001068)1176426412257976495Rat
1354624Cm35Cardiac mass QTL355.7heart left ventricle mass (VT:0007031)calculated heart weight (CMO:0000073)1177227632256448636Rat
1354652Kidm20Kidney mass QTL 204.3kidney mass (VT:0002707)calculated kidney weight (CMO:0000160)1177227632256448636Rat
634321Hc1Hypercalciuria QTL 12.91urine calcium amount (VT:0002985)urine calcium excretion rate (CMO:0000763)1178810256240830002Rat
1578763Kidm29Kidney mass QTL 293.30.0001kidney mass (VT:0002707)both kidneys wet weight (CMO:0000085)1179567751260522016Rat
737977Bp160Blood pressure QTL 1600.001arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)1181133855226133855Rat
8655655Arrd2Age-related retinal degeneration QTL 27.79retinal layer morphology trait (VT:0003727)percentage of study population developing retinopathy during a period of time (CMO:0002453)1183970203243914901Rat
8655855Arrd3Age-related retinal degeneration QTL 33.07lens clarity trait (VT:0001304)cataract incidence/prevalence measurement (CMO:0001585)1183970203243914901Rat
631838Niddm36Non-insulin dependent diabetes mellitus QTL 360.01insulin secretion trait (VT:0003564)calculated pancreatic islet insulin release measurement (CMO:0001217)1184550676229550676Rat
2312564Glom18Glomerulus QTL 182.40.003kidney glomerulus morphology trait (VT:0005325)index of glomerular damage (CMO:0001135)1185356336231689108Rat
1358898Bp255Blood pressure QTL 2553.6arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)1191019702246062233Rat
10059590Kidm44Kidney mass QTL 443.420.025kidney mass (VT:0002707)both kidneys wet weight to body weight ratio (CMO:0000340)1191033875236033875Rat
1358191Ept10Estrogen-induced pituitary tumorigenesis QTL 103.8pituitary gland mass (VT:0010496)pituitary gland wet weight (CMO:0000853)1192825253243914732Rat
8552891Epfw5Epididymal fat weight QTL 54.4epididymal fat pad mass (VT:0010421)epididymal fat pad weight to body weight ratio (CMO:0000658)1193113876238113876Rat
1600388Niddm67Non-insulin dependent diabetes mellitus QTL 675.840.000004blood glucose amount (VT:0000188)blood glucose level area under curve (AUC) (CMO:0000350)1195804352257091168Rat
1600395Niddm69Non-insulin dependent diabetes mellitus QTL 694.140.0002blood insulin amount (VT:0001560)plasma insulin level (CMO:0000342)1195804352257091168Rat
1600396Niddm68Non-insulin dependent diabetes mellitus QTL 684.970.0003blood glucose amount (VT:0000188)blood glucose level area under curve (AUC) (CMO:0000350)1195804352257091168Rat
631658Cm7Cardiac mass QTL 75.320.0001aorta mass (VT:0002845)aorta weight (CMO:0000076)1196248093241248093Rat
1358292Cm37Cardiac mass QTL 376.20.00000081heart mass (VT:0007028)heart weight to body weight ratio (CMO:0000074)1196248093241248093Rat
1600374Mcs17Mammary carcinoma susceptibility QTL 173mammary gland integrity trait (VT:0010552)mammary tumor number (CMO:0000343)1197670404242670404Rat
1641926Teswt2Testicular weight QTL 22.82testis mass (VT:1000644)both testes wet weight (CMO:0000175)1197697768238755659Rat
2302375Bw83Body weight QTL 834.870.0002body mass (VT:0001259)body weight (CMO:0000012)1197697768242697768Rat
61376Bp42Blood pressure QTL 4223.4arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)1197814409242814409Rat
1298084Thym4Thymus enlargement QTL 410.68thymus mass (VT:0004954)thymus weight to body weight ratio (CMO:0000612)1197814409242814409Rat
1357335Bw39Body weight QTL 393.3body mass (VT:0001259)body weight (CMO:0000012)1197814409242814409Rat
1331790Bp201Blood pressure QTL 2013.127arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)1198211513225126682Rat
634313Niddm43Non-insulin dependent diabetes mellitus QTL 43blood glucose amount (VT:0000188)blood glucose level (CMO:0000046)1199050459259647894Rat
2293694Bss38Bone structure and strength QTL 387.050.0001femur strength trait (VT:0010010)femur stiffness (CMO:0001674)1201554356246554356Rat
7394701Uae46Urinary albumin excretion QTL 463.60.0056urine albumin amount (VT:0002871)urine albumin excretion rate (CMO:0000757)1201554356246554356Rat
2300175Bmd40Bone mineral density QTL 4015.40.0001femur mineral mass (VT:0010011)bone mineral density (CMO:0001226)1201554356246554356Rat
2293655Bss36Bone structure and strength QTL 3610.660.0001femur strength trait (VT:0010010)femur ultimate force (CMO:0001675)1201554356246554356Rat
2293674Bss39Bone structure and strength QTL 397.10.0001femur strength trait (VT:0010010)femur total energy absorbed before break (CMO:0001677)1201554356246554356Rat
10059587Bw173Body weight QTL 1733.230.025body mass (VT:0001259)body weight (CMO:0000012)1202069611247069611Rat
1600363Hc6Hypercalciuria QTL 62.7urine calcium amount (VT:0002985)urine calcium excretion rate (CMO:0000763)1203995416244113296Rat
1600397Edcs4Endometrial carcinoma susceptibility QTL 42.2uterus morphology trait (VT:0001120)percentage of study population developing endometrioid carcinoma during a period of time (CMO:0001759)1206081677251081677Rat
1357399Bw45Body weight QTL 453.05body mass (VT:0001259)body mass index (BMI) (CMO:0000105)1206329708251329708Rat
1357404Bw42Body weight QTL 424.490.0001body mass (VT:0001259)body weight (CMO:0000012)1206329708251329708Rat
1300168Bp170Blood pressure QTL 1702.76arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)1207702246228581766Rat
1358916Kidm22Kidney mass QTL 223.32kidney mass (VT:0002707)both kidneys wet weight to body weight ratio (CMO:0000340)1210702053240947965Rat
1358890Bp259Blood pressure QTL 2593.06arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)1210702053260522016Rat
2292216Bw80Body weight QTL 803.230.0019body mass (VT:0001259)body weight (CMO:0000012)1213533809243914901Rat
724538Kidm1Kidney mass QTL 13.2kidney mass (VT:0002707)calculated kidney weight (CMO:0000160)1213707201252085212Rat
734768Niddm59Non-insulin dependent diabetes mellitus QTL 59body mass (VT:0001259)body weight (CMO:0000012)1213843987258843987Rat
634340Hcar5Hepatocarcinoma resistance QTL 58liver integrity trait (VT:0010547)liver tumorous lesion number (CMO:0001068)1214537555226660468Rat
61455Niddm7Non-insulin dependent diabetes mellitus QTL 75.5blood glucose amount (VT:0000188)plasma glucose level (CMO:0000042)1214537555238757011Rat
70211Niddm24Non-insulin dependent diabetes mellitus QTL 243.79blood glucose amount (VT:0000188)blood glucose level area under curve (AUC) (CMO:0000350)1214647894259647894Rat
1549910Bw54Body weight QTL 540.05body mass (VT:0001259)body weight (CMO:0000012)1214647894259647894Rat
61327Eae7Experimental allergic encephalomyelitis QTL 75.6body mass (VT:0001259)change in body weight (CMO:0002045)1216255568260522016Rat
2302040Pia35Pristane induced arthritis QTL 353.80.001blood immunoglobulin amount (VT:0002460)serum immunoglobulin G1 level (CMO:0002115)1216255568260522016Rat
1598821Rf55Renal function QTL 556.3renal blood flow trait (VT:2000006)ratio of change in renal blood flow to change in renal perfusion pressure (CMO:0001239)1218748008257976495Rat
61400Niddm1Non-insulin dependent diabetes mellitus QTL 111blood glucose amount (VT:0000188)blood glucose level (CMO:0000046)1218753689245907899Rat
724533Rf51Renal function QTL 515.30.0002kidney plasma flow trait (VT:0005524)renal plasma flow (CMO:0001914)1218753816256448513Rat
731175Uae20Urinary albumin excretion QTL 203.50.0018urine albumin amount (VT:0002871)urine albumin excretion rate (CMO:0000757)1221264111259647894Rat
10053715Scort24Serum corticosterone level QTL 242.130.0088blood corticosterone amount (VT:0005345)plasma corticosterone level (CMO:0001173)1221414816260522016Rat
724552Glom2Glomerulus QTL 23.30.0001kidney glomerulus morphology trait (VT:0005325)count of superficial glomeruli directly contacting the kidney surface (CMO:0001001)1222363780260522016Rat
1600392Bw123Body weight QTL 1230.001body mass (VT:0001259)body weight (CMO:0000012)1223201027260522016Rat
2293700Bmd27Bone mineral density QTL 276.60.0001femur mineral mass (VT:0010011)trabecular volumetric bone mineral density (CMO:0001729)1224054293243747962Rat
2293701Bmd34Bone mineral density QTL 348.30.0001femur strength trait (VT:0010010)femoral neck ultimate force (CMO:0001703)1224054293243747962Rat
734767Niddm57Non-insulin dependent diabetes mellitus QTL 57body mass (VT:0001259)body weight (CMO:0000012)1224054293260122809Rat
631843Bw116Body weight QTL 1164.10.016abdominal adipose amount (VT:1000220)abdominal fat pad weight (CMO:0000088)1224054293260122809Rat
734769Niddm58Non-insulin dependent diabetes mellitus QTL 58body mass (VT:0001259)body weight (CMO:0000012)1224569538260122809Rat

Markers in Region
WI-18746  
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.21224,845,372 - 224,845,521 (+)MAPPERmRatBN7.2
Rnor_6.01245,268,658 - 245,268,806NCBIRnor6.0
Rnor_5.01252,518,172 - 252,518,320UniSTSRnor5.0
RGSC_v3.41230,697,669 - 230,697,817UniSTSRGSC3.4
Celera1222,032,723 - 222,032,871UniSTS
Cytogenetic Map1q51UniSTS
09.MMHAP31FLC3.seq  
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.21224,842,817 - 224,842,968 (+)MAPPERmRatBN7.2
Rnor_6.01245,266,103 - 245,266,253NCBIRnor6.0
Rnor_5.01252,515,617 - 252,515,767UniSTSRnor5.0
RGSC_v3.41230,695,114 - 230,695,264UniSTSRGSC3.4
Celera1222,030,168 - 222,030,318UniSTS
Cytogenetic Map1q51UniSTS
RH94526  
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.21224,845,310 - 224,845,416 (+)MAPPERmRatBN7.2
Rnor_6.01245,268,596 - 245,268,701NCBIRnor6.0
Rnor_5.01252,518,110 - 252,518,215UniSTSRnor5.0
RGSC_v3.41230,697,607 - 230,697,712UniSTSRGSC3.4
Celera1222,032,661 - 222,032,766UniSTS
RH 3.4 Map11610.4UniSTS
Cytogenetic Map1q51UniSTS


Expression


RNA-SEQ Expression
High: > 1000 TPM value   Medium: Between 11 and 1000 TPM
Low: Between 0.5 and 10 TPM   Below Cutoff: < 0.5 TPM

alimentary part of gastrointestinal system circulatory system endocrine system exocrine system hemolymphoid system hepatobiliary system integumental system musculoskeletal system nervous system renal system reproductive system respiratory system appendage
High
Medium 1 31 8 7 8 11 68 32 34 11 8
Low 2 12 43 35 12 35 6 3 7
Below cutoff 6 6 6

Sequence


Reference Sequences
RefSeq Acc Id: ENSRNOT00000035814   ⟹   ENSRNOP00000036229
RefSeq Status:
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl1224,814,377 - 224,845,914 (+)Ensembl
Rnor_6.0 Ensembl1245,237,736 - 245,269,205 (+)Ensembl
RefSeq Acc Id: ENSRNOT00000106818   ⟹   ENSRNOP00000091849
RefSeq Status:
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl1224,814,571 - 224,845,920 (+)Ensembl
RefSeq Acc Id: NM_013155   ⟹   NP_037287
RefSeq Status: VALIDATED
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
mRatBN7.21224,814,456 - 224,845,920 (+)NCBI
Rnor_6.01245,237,736 - 245,269,205 (+)NCBI
Rnor_5.01252,485,275 - 252,523,202 (+)NCBI
RGSC_v3.41230,666,736 - 230,697,748 (+)RGD
Celera1222,002,111 - 222,033,270 (+)NCBI
Sequence:
RefSeq Acc Id: XM_006231197   ⟹   XP_006231259
RefSeq Status:
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
mRatBN7.21224,813,539 - 224,850,400 (+)NCBI
Rnor_6.01245,236,819 - 245,273,688 (+)NCBI
Rnor_5.01252,485,275 - 252,523,202 (+)NCBI
Sequence:
RefSeq Acc Id: XM_006231198   ⟹   XP_006231260
RefSeq Status:
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
mRatBN7.21224,814,022 - 224,850,400 (+)NCBI
Rnor_6.01245,237,281 - 245,273,688 (+)NCBI
Rnor_5.01252,485,275 - 252,523,202 (+)NCBI
Sequence:
RefSeq Acc Id: XM_006231199   ⟹   XP_006231261
RefSeq Status:
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
mRatBN7.21224,814,304 - 224,850,400 (+)NCBI
Rnor_6.01245,237,823 - 245,273,688 (+)NCBI
Rnor_5.01252,485,275 - 252,523,202 (+)NCBI
Sequence:
RefSeq Acc Id: XM_017588829   ⟹   XP_017444318
RefSeq Status:
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
mRatBN7.21224,814,298 - 224,850,400 (+)NCBI
Rnor_6.01245,237,823 - 245,273,688 (+)NCBI
Sequence:
RefSeq Acc Id: XM_017588830   ⟹   XP_017444319
RefSeq Status:
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
mRatBN7.21224,814,300 - 224,850,400 (+)NCBI
Rnor_6.01245,237,823 - 245,273,688 (+)NCBI
Sequence:
RefSeq Acc Id: XM_039102103   ⟹   XP_038958031
RefSeq Status:
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
mRatBN7.21224,813,940 - 224,850,400 (+)NCBI
Reference Sequences
RefSeq Acc Id: NP_037287   ⟸   NM_013155
- Peptide Label: precursor
- UniProtKB: F1LPV2 (UniProtKB/TrEMBL)
- Sequence:
RefSeq Acc Id: XP_006231259   ⟸   XM_006231197
- Peptide Label: isoform X1
- UniProtKB: F1LPV2 (UniProtKB/TrEMBL)
- Sequence:
RefSeq Acc Id: XP_006231260   ⟸   XM_006231198
- Peptide Label: isoform X1
- UniProtKB: F1LPV2 (UniProtKB/TrEMBL)
- Sequence:
RefSeq Acc Id: XP_006231261   ⟸   XM_006231199
- Peptide Label: isoform X2
- Sequence:
RefSeq Acc Id: XP_017444318   ⟸   XM_017588829
- Peptide Label: isoform X3
- Sequence:
RefSeq Acc Id: XP_017444319   ⟸   XM_017588830
- Peptide Label: isoform X4
- Sequence:
RefSeq Acc Id: ENSRNOP00000036229   ⟸   ENSRNOT00000035814
RefSeq Acc Id: XP_038958031   ⟸   XM_039102103
- Peptide Label: isoform X1
- UniProtKB: F1LPV2 (UniProtKB/TrEMBL)
RefSeq Acc Id: ENSRNOP00000091849   ⟸   ENSRNOT00000106818
Protein Domains
EGF-like   LDL-receptor class A

Protein Structures
Name Modeler Protein Id AA Range Protein Structure
AF-P98166-F1-model_v2 AlphaFold P98166 1-873 view protein structure

Transcriptome

eQTL   View at Phenogen
WGCNA   View at Phenogen
Tissue/Strain Expression   View at Phenogen

Promoters
RGD ID:13690836
Promoter ID:EPDNEW_R1361
Type:initiation region
Name:Vldlr_2
Description:very low density lipoprotein receptor
SO ACC ID:SO:0000170
Source:EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)
Alternative Promoters:null; see alsoEPDNEW_R1362  
Experiment Methods:Single-end sequencing.
Position:
Rat AssemblyChrPosition (strand)Source
Rnor_6.01245,237,719 - 245,237,779EPDNEW
RGD ID:13690838
Promoter ID:EPDNEW_R1362
Type:initiation region
Name:Vldlr_1
Description:very low density lipoprotein receptor
SO ACC ID:SO:0000170
Source:EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)
Alternative Promoters:null; see alsoEPDNEW_R1361  
Experiment Methods:Single-end sequencing.
Position:
Rat AssemblyChrPosition (strand)Source
Rnor_6.01245,237,862 - 245,237,922EPDNEW

Additional Information

Database Acc Id Source(s)
AGR Gene RGD:3963 AgrOrtholog
BioCyc Gene G2FUF-56030 BioCyc
Ensembl Genes ENSRNOG00000027491 Ensembl, ENTREZGENE, UniProtKB/TrEMBL
Ensembl Protein ENSRNOP00000036229 ENTREZGENE
  ENSRNOP00000036229.2 UniProtKB/TrEMBL
  ENSRNOP00000091849.1 UniProtKB/TrEMBL
Ensembl Transcript ENSRNOT00000035814 ENTREZGENE
  ENSRNOT00000035814.4 UniProtKB/TrEMBL
  ENSRNOT00000106818.1 UniProtKB/TrEMBL
Gene3D-CATH 2.120.10.30 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  4.10.400.10 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Laminin UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
InterPro 6-blade_b-propeller_TolB-like UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  EGF-like_Ca-bd_dom UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  EGF-like_dom UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  EGF-type_Asp/Asn_hydroxyl_site UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  EGF_Ca-bd_CS UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Growth_fac_rcpt_cys_sf UniProtKB/Swiss-Prot
  LDL_receptor-like_sf UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  LDLR_class-A_CS UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  LDLR_classB_rpt UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  LDrepeatLR_classA_rpt UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
KEGG Report rno:25696 UniProtKB/TrEMBL
NCBI Gene 25696 ENTREZGENE
PANTHER LOW-DENSITY LIPOPROTEIN RECEPTOR-RELATED UniProtKB/Swiss-Prot
  LOW-DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 2 UniProtKB/TrEMBL
  LOW-DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 2-RELATED UniProtKB/TrEMBL
  PTHR24270:SF16 UniProtKB/Swiss-Prot
Pfam EGF_CA UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  FXa_inhibition UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Ldl_recept_a UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Ldl_recept_b UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
PhenoGen Vldlr PhenoGen
PRINTS LDLRECEPTOR UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
PROSITE ASX_HYDROXYL UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  EGF_2 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  EGF_3 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  EGF_CA UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  LDLRA_1 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  LDLRA_2 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  LDLRB UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
SMART EGF UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  EGF_CA UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  LDLa UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  SM00135 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
Superfamily-SCOP EGF/Laminin UniProtKB/TrEMBL
  SSF57184 UniProtKB/Swiss-Prot
  SSF57424 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  YWTD domain UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
TIGR TC230870
UniProt A0A8I6ACI8_RAT UniProtKB/TrEMBL
  F1LPV2 ENTREZGENE, UniProtKB/TrEMBL
  P98166 ENTREZGENE, UniProtKB/Swiss-Prot


Nomenclature History
Date Current Symbol Current Name Previous Symbol Previous Name Description Reference Status
2002-06-10 Vldlr  Very low density lipoprotein receptor      Symbol and Name status set to approved 70586 APPROVED